CrushSCI.com
159.2Average days
127Median days
23Fastest days
302Longest days
512025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

98 days

Co-targeting ASAH1 and the histone reader BRD1 potently suppresses TNBC growth through the transcriptional repressor BCL6

Authors
Siva Chander Chabattula; Patrick T. Ball; Alok Kartha; Kiran Kumar Reddi; Yvonne J. K. Edwards; Romi GuptaShow moreShow less
Affiliations
1. Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, USA; 2. O’Neal Comprehensive Cancer Center at The University of Alabama at Birmingham, Birmingham, USAShow moreShow less
Source PDF DOI Publisher page
134 days

Metabolic and epigenetic reprogramming as novel vulnerabilities in renal cell carcinoma

Authors
Angela Cappello; Giuseppina Leuzzi; Lavinia Ferrone; Laura Cosmai; Sara Di Bari; Luciano Mutti; Camillo Porta; Carlo GaniniShow moreShow less
Affiliations
1. Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, Bari, Italy; 2. Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy; 3. Division of Nephrology and Dialysis, Onconephrology Outpatient Clinic, UOC Nephrology and Dialysis, ASST Fatebenefratelli Sacco, Fatebenefratelli Hospital, Milan, Italy; 4. UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy; 5. National Research Council. CNR, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
225 days

Macrophage-mediated extracellular matrix remodeling awakens dormant breast cancer cells

Authors
Kitti Jenovai; Pascal Lopez; Enora Lecorgne; Isabelle Bourget; Alexandra Mousset; Lola Bellone; Milena Bellon; Florian Tuffin; Stoyan Ivanov; Giulia Chinetti; Jean Albrengues; Cedric GaggioliShow moreShow less
Affiliations
1. INSERM U1081, CNRS UMR7284, Nice (IRCAN) Medical School, Institute for Research on Cancer and Aging, Université Côte d’Azur, Nice, France; 2. IHU RespirERA, CNRS UMR7284, INSERM U1081, Nice (IRCAN), Institute for Research on Cancer and Aging, Université Côte d’Azur, Nice, France; 3. CNRS, Université Côte d’Azur, Nice, France; 4. Laboratoire de Biochimie-Hormonologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, FranceShow moreShow less
Source PDF DOI Publisher page
204 days

SMPD3 enhances MHC-I surface presentation to drive CD8⁺ T-cell immunity in colorectal cancer

Authors
Bin Tan; Longzhu Zhong; Wentao Zeng; Nuozhou Weng; Jiayu Gu; Lianji Weng; Huilin Wen; Haocheng Xiao; Dandan Jin; Kehong ZhengShow moreShow less
Affiliations
1. Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 2. Department of General Surgery, Liwan Central Hospital of Guangzhou, Guangzhou, China; 3. Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
40 days

Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis

Authors
Feng Tian; Kangming Zhu; Yanfei Sun; Shuhua Guo; Xing Guo; Chuanxin Wang; Shuo XuShow moreShow less
Affiliations
1. Department of Clinical Laboratory, The Second Cheeloo Hospital of Shandong University, Jinan, China; 2. Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China; 3. Shandong Key Laboratory of Brain Health and Function Remodeling, Jinan, China; 4. Department of Hematology, Jining No. 1 People’s Hospital, Jining, ChinaShow moreShow less
Source PDF DOI Publisher page
127 days

Apoptosis-driven chromosomal rearrangements in cancer: CAD cleavage, nuclear architecture, and microhomology-mediated end joining

Authors
Sang-Nee TanShow moreShow less
Affiliations
1. Faculty of Medicine and Health Sciences, Department of Paraclinical Sciences, Universiti Malaysia Sarawak, Kota Samarahan, MalaysiaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Oncogenesis take to review a manuscript?

As of 2026-11-18, CrushSCI has 15 complete review records for Oncogenesis. The fastest paper went from submission to acceptance in 23 days (Metabolic plasticity and therapeutic opportunity in cancer, received 2026-05-13, accepted 2026-06-05); the slowest took 302 days. The average is 159.2 days and the median is 127 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.